MedTrace Logo

Information Systems Connectivity to Improve Medication Process

NCT06728254 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-09-24

No results posted yet for this study

Summary

Linked Care aims to help healthcare professionals (nurses, doctors, pharmacists) interact efficiently and safely with IT support to improve patient information flows. It focuses on the medication ordering process, which currently involves time-consuming steps like calling doctors and traveling to get prescriptions. The project targets nursing staff, doctors, pharmacists, and patients, with indirect benefits for hospitals, social welfare organizations, and insurance bodies. This study evaluates the Linked Care solution by addressing the research question: Does an electronic ordering system improve the efficiency and quality of the regular medication process?

Conditions

  • Medication Management at Home

Interventions

DEVICE

medication management

The test system consists of: * Linked care platform (backend) which provides a new possibility of data exchange for IT systems of caregivers, pharmacies, and GPs * User interfaces for caregivers as well as for the systems myneva.carecenter and mynevaTOgo * An extension of the user interface for GPs in their IT system (in the test only for the physician software PCPO by CompoGroup Medical ) * An extension of the user interface for pharmacists in their IT system (in the test only for pharmacies with software from Apothekerverlag) Functionally, the solution should, coordinate the medication requirements between pharmacies, GPs, and caregivers (subarea medication).

OTHER

Usual Care Group

Usual care.

Sponsors & Collaborators

  • Wiener Rotes Kreuz- Rettungs-, Krankentransport-, Pflege- und Betreuungsgesellschaft m.b.H.

    collaborator UNKNOWN

  • Volkshilfe Wien gemeinnützige Betriebs-GmbH

    collaborator UNKNOWN

  • Volkshilfe Gesundheits- und Soziale Dienste GmbH

    collaborator UNKNOWN

  • Johanniter Österreich Ausbildung und Forschung gem. GmbH

    collaborator UNKNOWN

  • Peter Putz

    lead OTHER

Principal Investigators

  • Elisabeth Haslinger-Baumann, FH-Prof. Dr. · FH Campus Wien University of Apllied Sciences

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-07
Primary Completion
2025-06-29
Completion
2025-06-29

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06728254 on ClinicalTrials.gov